Statistical issues in trials of preexposure prophylaxis.

about

HIV prevention trial design in an era of effective pre-exposure prophylaxis.The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agents.

P2860

Q45961960-0EC5A466-9EDF-49F1-9796-7B33CED93413 Q55460844-BDD65E5D-FB01-4314-9329-429963B57742

P2860

Statistical issues in trials of preexposure prophylaxis.

Item

http://www.wikidata.org/entity/Q36818077

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Statistical issues in trials of preexposure prophylaxis.

@ast

Statistical issues in trials of preexposure prophylaxis.

@en

type

Item

label

Statistical issues in trials of preexposure prophylaxis.

@ast

Statistical issues in trials of preexposure prophylaxis.

@en

prefLabel

Statistical issues in trials of preexposure prophylaxis.

@ast

Statistical issues in trials of preexposure prophylaxis.

@en

P1476

Statistical issues in trials of preexposure prophylaxis.

@en

P2093

David T Dunn

http://www.w3.org/2001/XMLSchema#string

David V Glidden

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis

Preexposure prophylaxis for HIV infection among African women

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial.

Tenofovir-based preexposure prophylaxis for HIV infection among African women.

HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.

Risk compensation: the Achilles' heel of innovations in HIV prevention?

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

P304

116-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1097/COH.0000000000000218

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26545264

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

preventive health services

biomedical investigative technique

P932

4838412

http://www.w3.org/2001/XMLSchema#string

Statistical issues in trials of preexposure prophylaxis.

about

P2860

P2860

Statistical issues in trials of preexposure prophylaxis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932